MXCT · Categories · Form 4

MXCT - SEC Form 4 insider transactions

MaxCyte Inc. (MXCT) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for MXCT

• 60d
  SEC Form 4 filed by Ahuja Parmeet

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 67d
  SEC Form 4 filed by Ahuja Parmeet

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 77d
  SEC Form 4 filed by Masoud Maher

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 89d
  SEC Form 4 filed by Swirsky Douglas J

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 293d
  Director Hemrajani Rekha sold $22,378 worth of shares (10,684 units at $2.09), decreasing direct ownership by 21% to 39,893 units (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 358d
  Director Johnston John Joseph was granted 29,210 shares, increasing direct ownership by 21% to 171,160 units (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 358d
  Director Hemrajani Rekha was granted 29,210 shares, increasing direct ownership by 137% to 50,577 units (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 358d
  Director Erck Stanley C was granted 29,210 shares, increasing direct ownership by 11% to 298,328 units (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 358d
  Director Douglas Richard was granted 29,210 shares, increasing direct ownership by 24% to 150,577 units (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 358d
  Director Collins Cynthia was granted 29,210 shares, increasing direct ownership by 57% to 80,889 units (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 358d
  Director Brooke William W was granted 29,210 shares, increasing direct ownership by 41% to 100,879 units (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 358d
  Director Balthrop Patrick J was granted 29,210 shares, increasing direct ownership by 137% to 50,577 units (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 358d
  Director Al-Wakeel Yasir B. was granted 29,210 shares, increasing direct ownership by 137% to 50,577 units (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 453d
  Chief Commercial Officer Soleymannezhad Ali sold $3,850 worth of shares (1,211 units at $3.18), decreasing direct ownership by 2% to 59,439 units (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 453d
  GENERAL COUNSEL Sandoval David I. sold $1,122 worth of shares (353 units at $3.18), decreasing direct ownership by 0.55% to 64,219 units (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 453d
  CHIEF FINANCIAL OFFICER Swirsky Douglas J sold $22,061 worth of shares (6,939 units at $3.18), decreasing direct ownership by 6% to 111,811 units (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 455d
  Chief Commercial Officer Soleymannezhad Ali was granted 34,625 shares, increasing direct ownership by 133% to 60,650 units (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 455d
  GENERAL COUNSEL Sandoval David I. was granted 23,125 shares, increasing direct ownership by 56% to 64,572 units (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 455d
  CHIEF FINANCIAL OFFICER Swirsky Douglas J was granted 37,500 shares, increasing direct ownership by 46% to 118,750 units (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 455d
  SEC Form 4 filed by President and CEO Masoud Maher

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 503d
  Director Johnston John Joseph sold $13,935 worth of shares (3,000 units at $4.64) and exercised 3,000 shares at a strike of $2.93 (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 518d
  GENERAL COUNSEL Sandoval David I. sold $20,272 worth of shares (4,466 units at $4.54), decreasing direct ownership by 10% to 41,447 units (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 533d
  Director Johnston John Joseph sold $12,021 worth of shares (3,000 units at $4.01) and exercised 3,000 shares at a strike of $2.93 (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 553d
  Director Johnston John Joseph exercised 3,000 shares at a strike of $2.45 and sold $11,328 worth of shares (3,000 units at $3.78) (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 588d
  Director Erck Stanley C exercised 47,689 shares at a strike of $0.04 and sold $177,403 worth of shares (47,689 units at $3.72) (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 594d
  Director Johnston John Joseph exercised 3,000 shares at a strike of $2.93 and sold $11,166 worth of shares (3,000 units at $3.72) (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 608d
  Director Collins Cynthia was granted 51,679 shares (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 622d
  Director Erck Stanley C exercised 47,689 shares at a strike of $0.04 and sold $178,752 worth of shares (47,689 units at $3.75) (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 624d
  Director Johnston John Joseph exercised 3,000 shares at a strike of $2.93 and sold $11,460 worth of shares (3,000 units at $3.82) (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 636d
  Chief Commercial Officer Soleymannezhad Ali was granted 10,400 shares, increasing direct ownership by 67% to 26,025 units (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 649d
  Director Erck Stanley C exercised 47,689 shares at a strike of $0.04 and sold $191,655 worth of shares (47,689 units at $4.02) (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 657d
  Director Johnston John Joseph exercised 3,000 shares at a strike of $2.93 and sold $12,840 worth of shares (3,000 units at $4.28) (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 680d
  EVP, GLOBAL SALES Ross Thomas M. exercised 33,333 shares at a strike of $1.64 and sold $148,135 worth of shares (33,333 units at $4.44) (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 686d
  Director Johnston John Joseph exercised 3,000 shares at a strike of $2.93 and sold $14,238 worth of shares (3,000 units at $4.75) (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 706d
  EVP, GLOBAL SALES Ross Thomas M. exercised 33,333 shares at a strike of $1.64 and sold $134,366 worth of shares (33,333 units at $4.03) (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 715d
  Director Johnston John Joseph exercised 10,000 shares at a strike of $2.28 and sold $39,900 worth of shares (10,000 units at $3.99) (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 722d
  EVP, GLOBAL SALES Ross Thomas M. exercised 33,333 shares at a strike of $1.64 and sold $136,465 worth of shares (33,333 units at $4.09) (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 733d
  Director Mandell Art was granted 21,367 shares, increasing direct ownership by 6% to 395,851 units (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 733d
  Director Douglas Richard was granted 21,367 shares, increasing direct ownership by 21% to 121,367 units (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 733d
  Director Hemrajani Rekha was granted 21,367 shares (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 733d
  Director Erck Stanley C was granted 21,367 shares, increasing direct ownership by 9% to 269,118 units (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 733d
  Director Al-Wakeel Yasir B. was granted 21,367 shares (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 733d
  Director Johnston John Joseph was granted 21,367 shares, increasing direct ownership by 18% to 141,950 units (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 733d
  Director Balthrop Patrick J was granted 21,367 shares (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 733d
  Director Brooke William W was granted 21,367 shares, increasing direct ownership by 42% to 71,669 units (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 810d
  Johnston John Joseph exercised 5,000 shares at a strike of $2.14 and sold $22,025 worth of shares (5,000 units at $4.41) (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 819d
  Ross Thomas M. was granted 25,000 shares (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 819d
  Sandoval David I. was granted 3,913 shares, increasing direct ownership by 9% to 45,913 units (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 819d
  Swirsky Douglas J was granted 81,250 shares (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 868d
  Johnston John Joseph exercised 5,000 shares at a strike of $2.14 and sold $25,585 worth of shares (5,000 units at $5.12) (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 894d
  SEC Form 4 filed by Masoud Maher

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 901d
  Johnston John Joseph exercised 5,000 shares at a strike of $2.14 and sold $22,650 worth of shares (5,000 units at $4.53) (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 923d
  Doerfler Douglas exercised 124,450 shares at a strike of $0.04 and sold $639,405 worth of shares (124,450 units at $5.14) (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 928d
  Doerfler Douglas sold $127,750 worth of shares (25,550 units at $5.00) and exercised 25,550 shares at a strike of $0.04 (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 930d
  Johnston John Joseph exercised 5,000 shares at a strike of $2.14 and sold $22,950 worth of shares (5,000 units at $4.59) (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 943d
  Johnston John Joseph exercised 10,000 shares at a strike of $1.71 and sold $37,100 worth of shares (10,000 units at $3.71) (SEC Form 4)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 1021d
  SEC Form 4: Johnston John Joseph exercised 5,000 shares at a strike of $1.64 and sold $18,500 worth of shares (5,000 units at $3.70)

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 1054d
  SEC Form 4 filed by Johnston John Joseph

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 1070d
  SEC Form 4 filed by Doerfler Douglas

  4 - MAXCYTE, INC. (0001287098) (Issuer)
• 1084d
  SEC Form 4 filed by Johnston John Joseph

  4 - MAXCYTE, INC. (0001287098) (Issuer)

Other MXCT categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends